271 related articles for article (PubMed ID: 15784688)
1. Evaluation of normal and neoplastic human mast cells for expression of CD172a (SIRPalpha), CD47, and SHP-1.
Florian S; Ghannadan M; Mayerhofer M; Aichberger KJ; Hauswirth AW; Schernthaner GH; Printz D; Fritsch G; Böhm A; Sonneck K; Krauth MT; Müller MR; Sillaber C; Sperr WR; Bühring HJ; Valent P
J Leukoc Biol; 2005 Jun; 77(6):984-92. PubMed ID: 15784688
[TBL] [Abstract][Full Text] [Related]
2. CD47-signal regulatory protein alpha (SIRPalpha) regulates Fcgamma and complement receptor-mediated phagocytosis.
Oldenborg PA; Gresham HD; Lindberg FP
J Exp Med; 2001 Apr; 193(7):855-62. PubMed ID: 11283158
[TBL] [Abstract][Full Text] [Related]
3. Expression and activation of signal regulatory protein alpha on astrocytomas.
Chen TT; Brown EJ; Huang EJ; Seaman WE
Cancer Res; 2004 Jan; 64(1):117-27. PubMed ID: 14729615
[TBL] [Abstract][Full Text] [Related]
4. Signal regulatory protein alpha ligation induces macrophage nitric oxide production through JAK/STAT- and phosphatidylinositol 3-kinase/Rac1/NAPDH oxidase/H2O2-dependent pathways.
Alblas J; Honing H; de Lavalette CR; Brown MH; Dijkstra CD; van den Berg TK
Mol Cell Biol; 2005 Aug; 25(16):7181-92. PubMed ID: 16055727
[TBL] [Abstract][Full Text] [Related]
5. The rat orthologue to the inhibitory receptor gp49B is expressed by neutrophils and monocytes, but not by NK cells or mast cells.
Bryceson YT; Torgersen KM; Inngjerdingen M; Berg SF; Hoelsbrekken SE; Fossum S; Dissen E
Eur J Immunol; 2005 Apr; 35(4):1230-9. PubMed ID: 15756648
[TBL] [Abstract][Full Text] [Related]
6. Sulfhydryl-2 domain-containing protein tyrosine phosphatase-1 is not a negative regulator of interleukin-4 signaling in murine mast cells.
White ED; Andrews RP; Hershey GK
J Leukoc Biol; 2001 May; 69(5):825-30. PubMed ID: 11358992
[TBL] [Abstract][Full Text] [Related]
7. Signal-regulatory protein alpha (SIRPalpha) but not SIRPbeta is involved in T-cell activation, binds to CD47 with high affinity, and is expressed on immature CD34(+)CD38(-) hematopoietic cells.
Seiffert M; Brossart P; Cant C; Cella M; Colonna M; Brugger W; Kanz L; Ullrich A; Bühring HJ
Blood; 2001 May; 97(9):2741-9. PubMed ID: 11313266
[TBL] [Abstract][Full Text] [Related]
8. The ability of protein tyrosine phosphatase SHP-1 to suppress NFkappaB can be inhibited by dominant negative mutant of SIRPalpha.
Neznanov N; Neznanova L; Kondratov RV; O'Rourke DM; Ullrich A; Gudkov AV
DNA Cell Biol; 2004 Mar; 23(3):175-82. PubMed ID: 15068587
[TBL] [Abstract][Full Text] [Related]
9. The N-terminal SH2 domain of the tyrosine phosphatase, SHP-2, is essential for Jak2-dependent signaling via the angiotensin II type AT1 receptor.
Godeny MD; Sayyah J; VonDerLinden D; Johns M; Ostrov DA; Caldwell-Busby J; Sayeski PP
Cell Signal; 2007 Mar; 19(3):600-9. PubMed ID: 17027227
[TBL] [Abstract][Full Text] [Related]
10. Signal regulatory proteins negatively regulate immunoreceptor-dependent cell activation.
Liénard H; Bruhns P; Malbec O; Fridman WH; Daëron M
J Biol Chem; 1999 Nov; 274(45):32493-9. PubMed ID: 10542295
[TBL] [Abstract][Full Text] [Related]
11. Negative regulation of hepatocellular carcinoma cell growth by signal regulatory protein alpha1.
Yan HX; Wang HY; Zhang R; Chen L; Li BA; Liu SQ; Cao HF; Qiu XH; Shan YF; Yan ZH; Wu HP; Tan YX; Wu MC
Hepatology; 2004 Sep; 40(3):618-28. PubMed ID: 15349900
[TBL] [Abstract][Full Text] [Related]
12. Membrane mobility and clustering of Integrin Associated Protein (IAP, CD47)--major differences between mouse and man and implications for signaling.
Subramanian S; Tsai R; Sen S; Dahl KN; Discher DE
Blood Cells Mol Dis; 2006; 36(3):364-72. PubMed ID: 16697668
[TBL] [Abstract][Full Text] [Related]
13. Essential roles of SIRPα in homeostatic regulation of skin dendritic cells.
Iwamura H; Saito Y; Sato-Hashimoto M; Ohnishi H; Murata Y; Okazawa H; Kanazawa Y; Kaneko T; Kusakari S; Kotani T; Nojima Y; Matozaki T
Immunol Lett; 2011 Mar; 135(1-2):100-7. PubMed ID: 20955735
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical assessment of CD25 is equally sensitive and diagnostic in mastocytosis compared to flow cytometry.
Baumgartner C; Sonneck K; Krauth MT; Kneidinger M; Födinger M; Hauswirth AW; Müllauer L; Valent P
Eur J Clin Invest; 2008 May; 38(5):326-35. PubMed ID: 18363719
[TBL] [Abstract][Full Text] [Related]
15. Substrate specificity of protein tyrosine phosphatase: differential behavior of SHP-1 and SHP-2 towards signal regulation protein SIRPalpha1.
Mishra AK; Zhang A; Niu T; Yang J; Liang X; Zhao ZJ; Zhou GW
J Cell Biochem; 2002; 84(4):840-6. PubMed ID: 11835408
[TBL] [Abstract][Full Text] [Related]
16. KIT polymorphisms and mutations determine responses of neoplastic mast cells to bafetinib (INNO-406).
Peter B; Hadzijusufovic E; Blatt K; Gleixner KV; Pickl WF; Thaiwong T; Yuzbasiyan-Gurkan V; Willmann M; Valent P
Exp Hematol; 2010 Sep; 38(9):782-91. PubMed ID: 20685234
[TBL] [Abstract][Full Text] [Related]
17. Signal regulatory protein (SIRPalpha), a cellular ligand for CD47, regulates neutrophil transmigration.
Liu Y; Bühring HJ; Zen K; Burst SL; Schnell FJ; Williams IR; Parkos CA
J Biol Chem; 2002 Mar; 277(12):10028-36. PubMed ID: 11792697
[TBL] [Abstract][Full Text] [Related]
18. SIRPα/CD172a regulates eosinophil homeostasis.
Verjan Garcia N; Umemoto E; Saito Y; Yamasaki M; Hata E; Matozaki T; Murakami M; Jung YJ; Woo SY; Seoh JY; Jang MH; Aozasa K; Miyasaka M
J Immunol; 2011 Sep; 187(5):2268-77. PubMed ID: 21775684
[TBL] [Abstract][Full Text] [Related]
19. Negative regulation of growth hormone receptor/JAK2 signaling by signal regulatory protein alpha.
Stofega MR; Argetsinger LS; Wang H; Ullrich A; Carter-Su C
J Biol Chem; 2000 Sep; 275(36):28222-9. PubMed ID: 10842184
[TBL] [Abstract][Full Text] [Related]
20. Oxidation sensitivity of the catalytic cysteine of the protein-tyrosine phosphatases SHP-1 and SHP-2.
Weibrecht I; Böhmer SA; Dagnell M; Kappert K; Ostman A; Böhmer FD
Free Radic Biol Med; 2007 Jul; 43(1):100-10. PubMed ID: 17561098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]